Matthew Perrone
Whittier Daily News
Washington, DC, United States
Contact Matthew
Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
| Recent: |
|
| Past: |
|
Past articles by Matthew:
Parents hunting for baby formula as shortage spans US
WASHINGTON (AP) — Parents across the U.S. are scrambling to find baby formula because supply disruptions and a massive safety recall have swept many leading brands off store shelves. → Read More
US experts wrestle with how to update COVID-19 vaccines
WASHINGTON (AP) — More than two years into the COVID-19 pandemic, U.S. health officials are beginning to grapple with how to keep the vaccines updated to best protect Americans from the ever-… → Read More
FDA OKs another Pfizer, Moderna COVID booster for 50 and up
U.S. regulators on Tuesday authorized another COVID-19 booster for people age 50 and older, a step to offer extra protection for the most vulnerable in case the coronavirus rebounds. → Read More
Pfizer asks FDA to allow COVID-19 vaccine for kids under 5
WASHINGTON (AP) — Pfizer on Tuesday asked the U.S. to authorize extra-low doses of its COVID-19 vaccine for children under 5, potentially opening the way for the very youngest Americans to st… → Read More
US regulators lift in-person restrictions on abortion pill
WASHINGTON (AP) — The Food and Drug Administration on Thursday permanently loosened several key restrictions on abortion pills, including a long-standing requirement that the medication be pi… → Read More
Pfizer confirms COVID pill’s results, potency versus omicron
WASHINGTON (AP) — Pfizer said Tuesday that its experimental pill to treat COVID-19 appears effective against the omicron variant. → Read More
US panel backs first-of-a-kind COVID-19 pill from Merck
WASHINGTON (AP) — A panel of U.S. health advisers on Tuesday narrowly backed a closely watched COVID-19 pill from Merck, setting the stage for a likely authorization of the first drug that Am… → Read More
Panel weighs safety, effectiveness of Merck’s COVID-19 pill
WASHINGTON (AP) — A panel of U.S. health advisers on Tuesday narrowly backed a closely watched COVID-19 pill from Merck, setting the stage for a likely authorization of the first drug that Am… → Read More
FDA: Merck COVID pill effective, experts will review safety
Federal health regulators say an experimental COVID-19 pill from Merck is effective against the virus, but they will seek input from outside experts on risks of birth defects and other potential pr… → Read More
US expands COVID boosters to all adults, final hurdle ahead
WASHINGTON (AP) — U.S. regulators on Friday moved to open up COVID-19 booster shots to all adults, expanding the government’s campaign to shore up protection and get ahead of rising cor… → Read More
FDA paves way for Pfizer COVID-19 vaccinations in young kids
WASHINGTON (AP) — The Food and Drug Administration on Friday paved the way for children ages 5 to 11 to get Pfizer’s COVID-19 vaccine. → Read More
Pfizer says COVID-19 vaccine more than 90% effective in kids
Kid-size doses of Pfizer’s COVID-19 vaccine appear safe and nearly 91% effective at preventing symptomatic infections in 5- to 11-year-olds, according to study details released Friday as the … → Read More
New FDA chief can’t come soon enough for beleaguered agency
WASHINGTON (AP) — Straining under a pandemic workload and battered by a string of public controversies, one of the leading agencies in the government’s fight against COVID-19 is finally… → Read More
J&J seeks US clearance for COVID-19 vaccine booster doses
WASHINGTON (AP) — Johnson & Johnson asked the Food and Drug Administration on Tuesday to allow extra shots of its COVID-19 vaccine as the U.S. government moves toward expanding its booste… → Read More
FDA panel is first key test for Biden COVID-19 booster plan
WASHINGTON (AP) — The Biden administration’s embattled plan to dispense COVID-19 booster shots to most Americans faced its first major hurdle Friday as a government advisory panel vigor… → Read More
US regulators give full approval to Pfizer COVID-19 vaccine
WASHINGTON (AP) — The U.S. gave full approval to Pfizer’s COVID-19 vaccine Monday, a milestone that could lift public confidence in the shots and spur more companies, universities and l… → Read More
US health officials call for booster shots against COVID-19
WASHINGTON (AP) — U.S. health officials Wednesday announced plans to dispense COVID-19 booster shots to all Americans to shore up their protection amid the surging delta variant and signs tha… → Read More
US allows 2 more over-the-counter COVID-19 home tests
WASHINGTON (AP) — U.S. health officials have authorized two more over-the-counter COVID-19 tests that can be used at home to get rapid results. → Read More
Government will propose banning flavors used in e-cigarettes
WASHINGTON (AP) — President Donald Trump said Wednesday his administration will propose banning thousands of flavors used in e-cigarettes to combat a recent surge in underage vaping . → Read More